EXPERT REACTION: The origins of COVID-19 (*preprint)

Embargoed until: Publicly released:
Not peer-reviewed: This work has not been scrutinised by independent experts, or the story does not contain research data to review (for example an opinion piece). If you are reporting on research that has yet to go through peer-review (eg. conference abstracts and preprints) be aware that the findings can change during the peer review process.

Systematic review: This type of study is a structured approach to reviewing all the evidence to answer a specific question. It can include a meta-analysis which is a statistical method of combining the data from multiple studies to get an overall result.

The most likely explanation for the origins of SARS-CoV-2, the virus behind the COVID-19 pandemic, is that it came from animals, according to a review of evidence led by an Australian expert.  The review is currently available as a preprint, which means it is not yet peer-reviewed. The authors say there is currently no evidence that SARS-CoV-2 has a laboratory origin and there is no evidence that any early cases had any connection to the Wuhan Institute of Virology, in contrast to the clear epidemiological links to animal markets in Wuhan. The authors also contend that there is a substantial body of scientific evidence supporting a zoonotic, or animal, origin for SARS-CoV-2.

Organisation/s: The University of Sydney, Doherty Institute for Infection and Immunity, The University of Melbourne, University of Otago

Funder: ECH is supported by an Australian Research Council Australian Laureate Fellowship (FL170100022). SAG is supported by the National Institutes of Health F32AI152341. JOW acknowledges support from the National Institutes of Health (AI135992). ALR acknowledges that VIDO receives operational funding from the Canada Foundation for Innovation - Major Science Initiatives Fund and from the Government of Saskatchewan through Innovation Saskatchewan and the Ministry of Agriculture. DLR acknowledges support of the Medical Research Council (MC_UU_12014/12) and the Wellcome Trust (220977/Z/20/Z). SJA acknowledges funding from the National Institute of Allergy and Infectious Diseases (R01AI149693). WB receives support from the Wellcome Trust (Z/205100 and Z/200187), BBSRC (BB/S008292) and MRC (MR/W005611/1). MFB acknowledges funding from the Bill and Melinda Gates Foundation (INV005517). JLG is supported by a New Zealand Royal Society Rutherford Discovery Fellowship This document is copyright of the authors. It is made available under a CC-BY-NC-ND 4.0 International license. (RDF-20-UOO-007). JLL is supported by the National Institutes of Health (R01AI141607, R21AI139738) and the National Science Foundation (Grant no. 2029949). SJN is supported by a Wellcome Trust Senior Fellowship (WT098049AIA), the Medical Research Council, and the Huo Family Charitable Foundation 2. TS was funded by the Austrian Science Fund (FWF) grant number P 28183. SRW is supported by the National Institutes of Health (R01AI140442, R01AI104887, R21AI138564, R21AI157147), as well as the Penn Center for Research on Coronaviruses and Other Emerging Pathogens. MW is supported by Bill and Melinda Gates Foundation INV004212 and the Arizona Board of Regents. KGA acknowledges support from the National Institutes of Health (U19AI135995, U01AI151812, and UL1TR002550). RFG is supported by the National Institutes of Health (R01AI132223, R01AI132244, U19AI135995, U54HG007480, U19AI142790, U01AI151812), the Coalition for Epidemic Preparedness Innovations (INTU1901 and ESEP1904) and the European & Developing Countries Clinical Trials Partnership (RIA2019LV-3053). AR acknowledges the support of the Wellcome Trust (Collaborators Award 206298/Z/17/Z – ARTIC network) and the European Research Council (grant agreement no. 725422 – ReservoirDOCS)

Media release

From: The University of Sydney

Leading biologists publish review of SARS-CoV-2 origin evidence

Edward Holmes and colleagues publish review article

Amid debate around the origins of SARS-CoV-2, leading global biologists have reviewed the scientific evidence to help clarify the origin of the virus that causes COVID-19 in humans.

  • Pre-print paper highlights links supporting zoonotic origin for the virus
  • Zero biological evidence exists for a laboratory leak
  • Focus on lab-leak distracting from work to prevent next pandemic

An international team of eminent biologists, led by Professor Edward Holmes from the University of Sydney and Professor Andrew Rambaut from the University of Edinburgh, has published a critical review paper on the origins of SARS-COV-2 as a pre-print on Zenodo.

The paper summarises and reviews the existing scientific evidence for the origin of the virus, which causes COVID-19 in humans, concluding that overwhelmingly its most likely origin is zoonotic – a transfer from an animal source to human infection. While the authors say that a laboratory accident “cannot be entirely dismissed” they emphasise that there currently exists zero evidence for such a laboratory origin.

Professor Holmes said: “Our careful and critical analysis of the currently available data provided no evidence for the idea that SARS-CoV-2 originated in a laboratory.”

The review paper says: “There is no evidence that any early cases had any connection to the Wuhan Institute of Virology (WIV), in contrast to the clear epidemiological links to animal markets in Wuhan, nor evidence that the WIV possessed or worked on a progenitor of SARS-CoV-2 prior to the pandemic.”

Rather, it argues that “there is substantial body of scientific evidence supporting a zoonotic origin for SARS-CoV-2”.

The 21 eminent scientists from universities and research institutes around the world warn that a focus on a highly improbable lab origin is distracting from the most urgent scientific tasks to “comprehensively investigate the zoonotic origin through collaborative and carefully coordinated studies”.

The authors warn that without a focus on this line of enquiry, the world will be “vulnerable to future pandemics” arising from new viruses.

As well as the University of Sydney and University of Edinburgh the affiliations of the 21 authors include the University of Utah (US), University of Saskatchewan (Canada), University of Glasgow (UK), University of California Berkeley (US), University of California San Diego (US), University of California Davis (US), Imperial College London (UK), Pennsylvania State University (US), the University of Melbourne at the Doherty Institute (Australia), The Wellcome Trust (UK), University of Otago (New Zealand), Jiaotong-Liverpool University (China), Texas A&M University (US), King’s College London at Guy’s Hospital (UK), Medical University of Vienna (Austria), University of Pennsylvania (US), University of Arizona (US), Scripps Research Institute (US), Tulane University (US), Zalgen Labs (US).

The pre-print paper will be submitted to a leading journal for peer review and publication.

Professor Holmes is not available for interview.

Attachments:

Note: Not all attachments are visible to the general public

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Dr Jemma Geoghegan, Evolutionary Virologist, University of Otago
Last updated: 09 Jul 2021 8:02am
Declared conflicts of interest:
Dr Jemma Geoghegan is a co-author of the study.

Dr Stuart Turville is an Associate Professor in the Immunovirology and Pathogenesis Program at UNSW Sydney's Kirby Institute

Prof Holmes and colleagues (among which are world leaders in viral molecular epidemiology) have outlined the evidence for and against the natural versus laboratory origins of SARS-CoV-2.

Prior to commenting further, I have no conflicts of interest with the listed authors. I have an interest in viral molecular epidemiology, but my core expertise is working with live viruses and their interface with host cells. The latter is especially focused on the role of viral glycoproteins.

On a separate note before commenting further, science is a deliberately slow business for a reason. It takes time to methodologically build up conclusions to support hypotheses. Whilst social media is great, it does not fit with this careful and stringent philosophy. In addition, it can and is populated with people working under pseudonyms where we have people with significant conflicts that are unknown and those commenting on the science do not have any background knowledge or experience of viruses (certainly not to the extent of any of the listed authors on this article). 

The work outlines the history of the appearance of related viruses from animal reservoirs. What have we learned from our past? History is the best place to start.

Eg. 'It displays clear similarities to SARS-CoV that spilled over into humans in Foshan, Guangdong province, China in November 2002, and again in Guangzhou, Guangdong province in 2003. Both these SARS-CoV emergence events were associated with markets selling live animals and involved species, particularly civets and raccoon dogs, that were also sold live in Wuhan markets in 2019 and are known to be susceptible to SARS-CoV-2 infection. Animal traders working in 2003, without a SARS diagnosis, were documented to have high levels of IgG to SARS-CoV (13% overall and >50% for traders specializing in civets).'

It also outlines the detective work taken to establish the link of SARS-CoV-1 to the animal reservoirs. Of note, there were active collaborative investigations looking not only at the animals but also the people closely associated with them. Our immune systems and those in animals give us traces of events in the past. Antibodies in someone’s blood towards a virus gives us the evidence their bodies have seen the virus prior. The work outlined before and listed by the authors needs to take a similar track for SARS-CoV-2. The detective work needs to continue.

The work presents the appearance of the virus over time. The data support the clear link to the Wuhan market, as is now well known. It states that animal carcasses were tested in the market but these were unrepresentative of the live animal species sold within the market. An inventory of the market animals is provided by links to reference 5, where a study was ongoing prior to 2019 to look at animal sales in the market. Drawing from the history of SARS-CoV-1, testing of animals needs to continue and encompass that outlined in the inventory (especially in animals like Civets and Raccoon dogs). Of note there was a signal for SARS-CoV-2 in the market at the western section that traded in wildlife and domestic animal products. This is outlined in the WHO report in reference 10.

The discussion then moves to the “lab leak” discussions. It states clearly in the conclusions that it cannot completely be dismissed. Rather the discussion in this manuscript focuses on the lack of evidence for this to be the case. This is based on:

1- Lack of epidemiological evidence that it started within the laboratory. The key source would be an infected worker that may have taken it home after being infected in the lab. Yet this is not documented in any early index cases and to date, laboratory workers like Shi Zhengli do not have antibodies that would highlight a previous exposure event. Investigation, one would assume, would be ongoing.

2- Lack of evidence the virus was engineered to be a good fit with humans. This I agree with. Although the virus could infect humans, it certainly does a better job now with the contemporary variants like Delta. In 2020, it changed to be better suited to humans. It did this via the pandemic and rampant global spread. 

3- Lack of signature motifs that tell us it is from a lab. Viruses do not need to be engineered to be in a lab. Many are “grown” from samples. They could have been grown from animal samples. Many virologists use Vero cells that are kidney cells from a monkey. If viruses are grown for too long within those cells, the virus changes in key areas to “adapt” to that setting. There are no signature changes that suggest this. It could have been grown in an animal. Yes, but SARS-CoV-2 doesn't infect rodents like mice very well. Mice can be engineered to be infected by enabling them to express the receptor human ACE2. If the latter was the case, would not the virus be better suited to humans? One could argue though, that it had made that step in this animal model and was why the pandemic started in the first place, only to become fitter in humans over time. The issue here again is the lack of evidence. It would need to have been transmitted to a lab worker to then move it from the lab into the community. There is not epidemiological evidence for this as listed above. 

4-They do state the evidence for lab breaches that did occur in the past for SARS-CoV-1. A bit of history like that outlined above for zoonotic animal transfer is always the best start. Working through how the epidemiology presented in the lab breach cases would present how the observations would look in this case vs the current lack of evidence for the SARS-CoV-2 case. Yet as outlined by the authors, there is presently no evidence to support the lab breach to date.

It is a well written thoughtful piece. It adds to the debate and updates the evidence based on what we know of the contemporary viral variants. Its authors have a significant track record in this area. They don't rule out a lab leak, rather they state the present evidence in front of us does not support this theory.

The 'slow and careful business' of science will continue. More evidence will be uncovered over time, The detective work will continue. It's important we keep that in mind. We are always learning.

Last updated: 08 Jul 2021 2:14pm
Declared conflicts of interest:
None declared.

Professor Edward Holmes is a ARC Australian Laureate Fellow from the University of Sydney. He is lead author on the review.

Our careful and critical analysis of the currently available data provided no evidence for the idea that SARS-CoV-2 originated in a laboratory.

Last updated: 08 Jul 2021 2:12pm
Declared conflicts of interest:
Conflict of Interest: Prof Holmes is the lead author of the review.

News for:

Australia
New Zealand
NSW
VIC
SA

Media contact details for this story are only visible to registered journalists.